Catheter associated urinary tract infection's (CAUTI) account for more than 80% of all healthcare associated infections (HAIs) as compared to non-catheterized urinary tract infections.
Introduction
Infections that patients acquire during hospital stay and receiving treatment for medical and surgical conditions are healthcare-associated infections [1] . Urinary tract infection is the most common bacterial infection that occurs in urinary tract and accounts for 40% of all hospital acquired infections [2] . The most common healthcare-associated infection is catheter-associated urinary tract infections which occur in patients after insertion of catheter and accounts for 30% to 40% of all the hospital acquired infections [3, 4] . Insertion of catheter in patients greater than 7 days accounts infection up to 25% and increases to 
Discussion
Extended spectrum β-lactamases production was identified in the early 1980s. Another study from Nagpur, India showed the prevalence of ESBLs to be 48.3% in urinary isolates [23]. 39.7% were female catheterized patients and 45.7% were in non-catheterized patients. There was no statistical difference between male and female patients (p = 0.137). The highest number of patients belonged to the Medicine Ward. In our region, there is a strong positive association between prior antibiotic use and ESBL production of the catheterized and non-catheterized patients (p = 0.047). 45.7%
of catheterized patients and 37.7% of non-catheterized patients have previously used 3 rd generation cephalosporins. The urine samples of these patients showed resistance of Escherichia coli and Klebsiella pneumoniae to the beta lactam drugs and are a major risk factor for ESBLs production. The only choice of drug for ESBL producing organisms is imipenem. The duration of catheterization and misuse of antibiotics were also risk factors for the emergence of resistance to drugs and thus treatment of these patients becomes difficult. It is necessary that catheterization in situ should not be greater than 3 days.
In-out catheterization pattern should follow hygienic conditions to decrease the spread of nosocomial infections and ESBL production.
Conclusion
A high frequency of ESBL producing organisms was found especially among Klebsiella pneumoniae and Escherichia coli in urinary isolates. ESBL producing organisms were found higher amongst catheterized patients associated with urinary tract infections as compared to non-catheterized patients associated with urinary tract infections. This is suggestive of a need for regular screening and surveillance for ESBL producing organisms. Since ESBLs destroy the cephalosporins given as first line antibiotics in hospitals, this leads to increased morbidity and mortality and therefore ESBLs are clinically important. Thus, accurate detection of these organisms is essential for effective treatment.
ESBL production from clinical specimens also reflects non-judicious use of antimicrobials. Patients infected with these organisms should be nursed with contact precautions to avoid the spread of nosocomial infection. Further typing and sub-typing of ESBLs based on gene sequencing by PCR is planned as continuation of this study. This will show the most common ESBL types in our clinical settings. This confers antibiotic resistance to specific group of antibiotics. It will equip the treating physicians with better treatment options for patients infected with ESBL producing organisms.
